Author
Listed:
- Juan-Miguel Guerras
(Centro Nacional de Epidemiología, Instituto de Salud Carlos III, 28029 Madrid, Spain
CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain)
- Juan Hoyos
(Departamento de Salud Pública y Materno-Infantil, Universidad Complutense de Madrid, 28040 Madrid, Spain)
- Patricia García de Olalla
(CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain
Servicio de Epidemiología, Agència de Salut Pública de Barcelona, 08023 Barcelona, Spain)
- Luis de la Fuente
(Centro Nacional de Epidemiología, Instituto de Salud Carlos III, 28029 Madrid, Spain
CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain)
- Lidia Herrero
(Centro Nacional de Epidemiología, Instituto de Salud Carlos III, 28029 Madrid, Spain)
- David Palma
(CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain
Servicio de Epidemiología, Agència de Salut Pública de Barcelona, 08023 Barcelona, Spain)
- Jorge del Romero
(Centro Sanitario Sandoval, Instituto de Investigación Sanitaria San Carlos, Hospital Clínico San Carlos, 28010 Madrid, Spain)
- Jorge-Néstor García-Pérez
(Unidad de ITS de Vall d’Hebron-Drassanes, Hospital Vall d’Hebron, 08001 Barcelona, Spain)
- María-José Belza
(CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain
Escuela Nacional de Sanidad, Instituto de Salud Carlos III, 28029 Madrid, Spain)
- The Methysos Project Group
(Methysosprojectgroup@hotmail.com.)
Abstract
This study compares the prevalence of drug use and the typologies of polydrug use (PDU) in men who have sex with men (MSM) and general population men (GPM). Participants were men aged 16–64, living in the provinces of Madrid and Barcelona: 1720 were recruited in a GPM survey, and 2658 were HIV-negative MSM from HIV/STIs diagnosis services. Lifetime and last-year prevalence of drug use and prevalence ratios (PRs) of MSM to GPM for the different drugs were calculated using Poisson regression. Latent class analysis (LCA) was performed to identify typologies of PDU. Lifetime use of the drugs considered was higher in MSM, and even higher for drug use in the last-year: PRs for cannabis, hallucinogens and cocaine ranged from 2–5; for amphetamine, ecstasy and methamphetamine 12–16; and above 60 for ketamine, GHB/GBL, inhalants and mephedrone. In the LCA for lifetime PDU four classes arose from the GPM (No-PDU (79.6%); Conventional PDU (13.8%); Intensive conventional PDU (4.9%); Heavy PDU (1.8%)) and four among MSM (No-PDU (57.7%); Conventional PDU plus poppers (18.8%); PDU preferring chemsex drugs (6.4%); Heavy PDU (17.2%)). For PDU during the last-year, three classes arose in the GPM: No-PDU (94.7%); Conventional PDU (4.3%); Heavy PDU (0.9%). For MSM, we identified four classes: No-PDU (64.7%); Conventional PDU plus poppers (15.6%); PDU preferring chemsex drugs (6.2%); Heavy PDU (13.5%). MSM should be considered a priority group for the prevention of the use of all drugs but the heterogeneity of PDU typologies regarding users’ preference towards conventional and/or sexualised drugs needs to be taken into account.
Suggested Citation
Juan-Miguel Guerras & Juan Hoyos & Patricia García de Olalla & Luis de la Fuente & Lidia Herrero & David Palma & Jorge del Romero & Jorge-Néstor García-Pérez & María-José Belza & The Methysos Project , 2021.
"Comparison of Polydrug Use Prevalences and Typologies between Men Who Have Sex with Men and General Population Men, in Madrid and Barcelona,"
IJERPH, MDPI, vol. 18(21), pages 1-14, November.
Handle:
RePEc:gam:jijerp:v:18:y:2021:i:21:p:11609-:d:672386
Download full text from publisher
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:21:p:11609-:d:672386. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.